Literature DB >> 19923351

Interleukin 2 targeted therapy in inflammatory bowel disease.

S Yarkoni, Y Sagiv, A Kaminitz, N Askenasy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19923351     DOI： 10.1136/gut.2008.175182

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

1.  Relationship between XspI Site Polymorphisms of LDL-R Gene and Serum IL-2 and IL-10 in Patients with Hypercholesterolemia.

Authors:  Mingming Zhang; Yamin Lu; Xin Liu; Xiaobin Zhang; Cuigai Zhang; Wei Gao; Yanqing Tie
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

2.  Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients.

Authors:  Aristea Sideri; Kyriaki Bakirtzi; David Q Shih; Hon Wai Koon; Phillip Fleshner; Razvan Arsenescu; Violeta Arsenescu; Jerrold R Turner; Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.